Furthermore, administration of the IL-6R antibody MR16-1 after MI suppressed myocardial inflammation causing impaired LV-remodeling and improved LV contractile function (123), but worsened LV remodeling following MI-R injury (124). The gene discussed is IL6R; the disease is myocardial infarction.